Skip to main content
. Author manuscript; available in PMC: 2022 Jul 7.
Published in final edited form as: Exp Eye Res. 2020 Jul 4;198:108135. doi: 10.1016/j.exer.2020.108135

Figure 6.

Figure 6.

ERG waveforms from Dog D at ages of 5 months (baseline #1), 8 months (baseline #2), and 10 months (end-stage disease). (A) pure rod, (B) mixed rod and cone, (C) pure cone, and (D) 30 Hz flicker responses all exhibited ERG preservation in the rhTPP1 treated eye relative to the control eye. Baseline #1 and #2 recordings were performed within 1 week prior to intravitreal injections #1 and #2, respectively.